Advanced Solid Tumors
Showing NaN - NaN of 58
Advanced Solid Tumors Trial in Worldwide (AMG 650)
Active, not recruiting
- Advanced Solid Tumors
- AMG 650
-
Los Angeles, California
- +21 more
Jan 26, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1948, nivolumab, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ASP1948
- +2 more
-
New Haven, Connecticut
- +41 more
Jan 10, 2023
Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- +3 more
- CCS1477
- +5 more
-
Boston, Massachusetts
- +21 more
Jan 10, 2023
Advanced Solid Tumors Trial in Worldwide (ASP1951, pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
-
Tucson, Arizona
- +31 more
Jan 10, 2023
NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- GDC-6036
- +6 more
-
Duarte, California
- +68 more
Jan 10, 2023
Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- Elimusertib (BAY1895344)
- Pembrolizumab
-
Palo Alto, California
- +15 more
Jan 6, 2023
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- ALKS 4230
- ALKS 4230 + pembrolizumab
-
Denver, Colorado
- +30 more
Nov 23, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)
Recruiting
- Advanced Solid Tumors
-
New Haven, Connecticut
- +19 more
Nov 10, 2022
Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)
Recruiting
- Advanced Solid Tumors
- FF-10850 Topotecan Liposome Injection
-
Scottsdale, Arizona
- +5 more
Oct 19, 2022
Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))
Active, not recruiting
- Advanced Solid Tumors
- DS-8201a (DP1)
- +2 more
-
San Diego, California
- +13 more
Oct 4, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,
Active, not recruiting
- Breast Cancer
- +2 more
- AZD5363
- +2 more
-
Middletown, New Jersey
- +2 more
Jul 5, 2022
Advanced Solid Tumors Trial in Worldwide (MSC2490484A (M3814), Fractionated RT, Cisplatin)
Completed
- Advanced Solid Tumors
- MSC2490484A (M3814)
- +2 more
-
Fresno, California
- +25 more
Apr 6, 2022
Advanced Solid Tumors Trial in United Kingdom, United States (MEDI5395, Durvalumab)
Active, not recruiting
- Advanced Solid Tumors
- MEDI5395
- Durvalumab
-
Phoenix, Arizona
- +9 more
Mar 22, 2022